Vineeta Agarwala

Thyme Care, Inc. is a leading value-based care partner that collaborates with payers and providers to transform the experience and outcomes for individuals living with cancer. Thyme Care is based in Nashville, TN. The company partners with health plans, employers, and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled care team and seamless integration with providers, creating a hybrid collaborative care delivery model that guides and supports the entire patient journey. The company empowers over 300 oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. The company was founded in 2020 by Bobby Green and Robin Shah. Robin Shah has been the CEO since 2020.

Waymark, Inc. is a Public Benefit Corporation based in San Francisco, CA. Waymark seeks to improve healthcare access and outcomes for people receiving Medicaid. The company is made up of healthcare providers, technologists, and builders who believe that people receiving Medicaid deserve great healthcare. Waymark enables community-based care, using technology, to catalyze improvements in access and outcomes for patients receiving Medicaid benefits. The company provides patients receiving Medicaid benefits with a community health worker, a therapist, or a pharmacist. The company was founded in 2021 by Sanjay Basu, Rajaie Batniji, with Rajaie Batniji serving as the CEO since 2021.

Stipple Bio Inc. operates as a biotechnology company. The company is based in Milford, CT. The CEO of the company is Aaron Ring.

Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation.

Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA.